Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126139431 | 12613943 | 1 | I | 20160726 | 20160802 | 20160802 | PER | US-PFIZER INC-2016363155 | PFIZER | 59.00 | YR | F | Y | 92.80000 | KG | 20160802 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126139431 | 12613943 | 1 | PS | VENLAFAXINE HCL | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 150 MG, 1X/DAY | 20699 | 150 | MG | QD | |||||||
| 126139431 | 12613943 | 2 | SS | VENLAFAXINE HCL | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 300 MG, DAILY | 20699 | 300 | MG | ||||||||
| 126139431 | 12613943 | 3 | SS | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | 50 MG, 1X/DAY | 19839 | 50 | MG | QD | ||||||||
| 126139431 | 12613943 | 4 | SS | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | 100 MG, 1X/DAY | 19839 | 100 | MG | QD | ||||||||
| 126139431 | 12613943 | 5 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | ONCE IN THE MORNING | 0 | 40 | MG | QD | ||||||||
| 126139431 | 12613943 | 6 | C | LOSARTAN. | LOSARTAN | 1 | 100 MG, 1X/DAY | 0 | 100 | MG | QD | ||||||||
| 126139431 | 12613943 | 7 | C | MYCOPHENOLATE | MYCOPHENOLIC ACID | 1 | TWO IN THE MORNING AND ONE AT NIGHT | 0 | 500 | MG | |||||||||
| 126139431 | 12613943 | 8 | C | BENLYSTA | BELIMUMAB | 1 | INFUSION ONCE A MONTH | 0 | /month | ||||||||||
| 126139431 | 12613943 | 9 | C | SOMA | CARISOPRODOL | 1 | Oral | ONE TABLET BY MOUTH AS NEEDED | 0 | 350 | MG | TABLET | |||||||
| 126139431 | 12613943 | 10 | C | SOMA | CARISOPRODOL | 1 | 0 | TABLET | |||||||||||
| 126139431 | 12613943 | 11 | C | ZOLPIDEM | ZOLPIDEMOLPIDEM TARTRATE | 1 | Oral | ONE TABLET BY MOUTH AS NEEDED | 0 | 10 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126139431 | 12613943 | 1 | Anxiety |
| 126139431 | 12613943 | 3 | Anxiety |
| 126139431 | 12613943 | 5 | Gastrooesophageal reflux disease |
| 126139431 | 12613943 | 6 | Hypertension |
| 126139431 | 12613943 | 7 | Systemic lupus erythematosus |
| 126139431 | 12613943 | 8 | Systemic lupus erythematosus |
| 126139431 | 12613943 | 9 | Back disorder |
| 126139431 | 12613943 | 10 | Musculoskeletal discomfort |
| 126139431 | 12613943 | 11 | Insomnia |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126139431 | 12613943 | Anxiety | |
| 126139431 | 12613943 | Condition aggravated | |
| 126139431 | 12613943 | Drug ineffective | |
| 126139431 | 12613943 | Prescribed overdose |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126139431 | 12613943 | 2 | 20160502 | 20160716 | 0 | |
| 126139431 | 12613943 | 4 | 20160624 | 0 |